The formation of inosine at the wobble position of eukaryotic tRNAs is an essential modification catalyzed 13 by the ADAT2/ADAT3 complex. In humans, a valine to methionine mutation (V144M) in ADAT3 that 14 originated ~1,600 years ago is the most common cause of autosomal-recessive intellectual disability (ID) 15 in Arabia. Here, we show that ADAT3-V144M exhibits perturbations in subcellular localization and has 16 increased propensity to form aggregates associated with cytoplasmic chaperonins. While ADAT2 co-17 expression can suppress the aggregation of ADAT3-V144M, the ADAT2/3 complexes assembled with 18 ADAT3-V144M exhibit defects in adenosine deaminase activity. Moreover, extracts from cell lines derived 19 from ID-affected individuals expressing only ADAT3-V144M display a reduction in tRNA deaminase 20 activity. Notably, we find that the same cell lines from ID-affected individuals exhibit decreased wobble 21 inosine in certain tRNAs. These results identify a role for ADAT2-dependent localization and folding of 22 ADAT3 in wobble inosine modification that is crucial for the developing human brain. 23
Introduction 25
The hydrolytic deamination of adenosine (A) to inosine (I) at the wobble position of tRNA is an 26 essential post-transcriptional tRNA modification in bacteria and eukaryotes (reviewed in (1-3). Since 27 inosine can pair with U, C or A, a single tRNA isoacceptor containing the inosine modification at the 28 wobble anticodon position can recognize up to three different codons containing a different nucleotide base 29 at the third position. Thus, the degeneracy provided by the wobble inosine modification is necessary for the 30 translation of C or A-ending codons in organisms that lack a cognate G or U34-containing anticodon tRNA 31 isoacceptor by expanding the reading capacity of tRNA isoacceptors (4). Moreover, it has been shown that 32 highly translated genes in eukaryotic organisms, including humans, are correlated with an enrichment in 33 wobble inosine tRNA-dependent codons, suggesting a critical role for tRNA inosine modification in 34 maintaining proper levels of protein expression (5, 6) . 35
In Escherichia coli, A to I conversion at the wobble position is present in a single tRNA Arg-ACG); and is catalyzed by the homodimeric complex TadA adenosine deaminase (7). In the yeast 37
Saccharomyces cerevisiae, wobble inosine modification occurs in seven different tRNAs and is catalyzed 38 by a heterodimeric enzyme complex consisting of the Tad2p and Tad3p subunits (8, 9) . Tad2p is the catalytic 39 subunit and contains a prototypical deaminase motif homologous to cytidine/deoxycytidine deaminases, 40 including a conserved glutamic acid residue within the active site that is necessary for proton shuttling in 41 the hydrolytic deamination reaction (10, 11) . Tad3p also contains a canonical deaminase motif but lacks the 42 conserved catalytic glutamate in the active site. However, Tad2p is inactive without Tad3p, indicating that 43 formation of a heterodimeric Tad2p/Tad3p complex is required for adenosine deaminase activity (8) . 44 Functional homologs of S. cerevisiae Tad2p and Tad3p have been identified in all eukaryotes to date, 45 including the human homologs . 46
Exome sequencing and autozygosity mapping have identified a single c.382G>A mutation in the 47 human ADAT3 gene that is causative for autosomal-recessive intellectual disability (ID) in multiple families 48 of Saudi Arabian descent (16, 17) . All reported individuals homozygous for the V144M mutation exhibit 49 cognitive deficits indicative of a neurodevelopmental disorder, with the majority displaying strabismus and 50 growth delay. Additional clinical features of individuals homozygous for the ADAT3-V144M mutation 51 include microcephaly, epilepsy, and occasional brain abnormalities such as white matter atrophy and 52 arachnoid cysts. Subsequent large-scale sequencing has identified this ancient founder mutation to be one 53 of the most common causes of autosomal recessive intellectual disability in patients from Saudi Arabia, 54 with a carrier frequency of ~1% (18) (19) (20) . However, the mechanistic cause of ADAT3-associated 55 pathogenesis remains unclear. 56
Based upon the longer of two mRNA transcripts encoded by the human ADAT3 gene, the ID-57 causing G>A transition results in a valine to methionine missense mutation at residue 144 (V144M) of the 58 encoded ADAT3 protein. The mutated valine residue is conserved from yeast to humans and is predicted 59 to perturb the surface structure of the ADAT3 protein (16). However, it is unknown how the V144M 60 mutation affects ADAT3 function and whether this would affect tRNA inosine modification levels in ID-61 affected individuals that are homozygous for the autosomal-recessive mutation. This would be important 62 wildtype (WT) exhibited diffuse cytoplasmic localization outlining the nucleus with only a small percentage 89 of transfected cells exhibiting GFP-ADAT3 signal in the nucleus ( Figure 1A , B, GFP-ADAT3-WT). The 90 absence of nuclear localization for GFP-ADAT3-WT is likely due to the limiting amounts of endogenous 91 ADAT2 subunit that is required for nuclear import of ADAT3 (15) . By contrast, the ADAT3-V144M 92 variant exhibited a distinct localization pattern with distribution in both the cytoplasm and nucleus rather 93 than the primarily cytoplasmic localization of ADAT3-WT ( Figure 1A, B) . In addition to aberrant nuclear 94 localization, we detected an increased population of GFP-positive cells that exhibited discrete, cytoplasmic 95 foci when transfected with the ADAT3-V144M variant (Figure 1A , C; GFP-ADAT3-V144M, arrowheads). 96
We also found that carboxy-terminal GFP-tagged ADAT3 exhibited the same aberrant nucleocytoplasmic 97 localization pattern and increased formation of cytoplasmic foci observed with N-terminal GFP-ADAT3 98 (Supplemental Figure 1 ). In addition, we found that the steady-state levels of GFP-ADAT3-V144M variant 99 was lower than ADAT3-WT ( Figure 1D , Supplemental Figure 1) , showing that the aberrant subcellular 100 localization pattern of ADAT3-V144M was not simply due to greater expression. 101
In contrast to the cytoplasmic localization of transiently expressed GFP-ADAT3-WT alone, the co-102 expression of ADAT2 with ADAT3-WT led to GFP-ADAT3-WT being localized to the nucleus with only 103 a minor proportion of signal remaining in the cytoplasm (Figure 1A , B; GFP-ADAT3-WT + ADAT2), 104 consistent with the observation that ADAT2 dimerization with ADAT3 is required for nuclear import of 105 the ADAT2/3 complex (15). Similarly, we found that co-expression of ADAT2 with ADAT3-V144M could 106 also induce the translocation of GFP-ADAT3-V144M into the nucleus (Figure 1A , B; GFP-ADAT3-107 V144M + ADAT2). The ability of ADAT2 co-expression to induce the translocation of GFP-ADAT3-108 V144M into the nucleus indicates that ADAT3-V144M can still interact with ADAT2. However, while a 109 slight diffuse signal of GFP-ADAT3-WT remained in the cytoplasm even with ADAT2 co-expression, the 110 ADAT3-V144M variant displayed much greater nuclear accumulation in the majority of cells ( Figure 1B) . 111
Remarkably, co-expression of ADAT2 with the ADAT3-V144M variant also reduced the percentage of 112 cells with cytoplasmic GFP-ADAT3 foci to nearly wildtype levels ( Figure 1C ). These results uncover an 113 aberrant subcellular localization pattern for ADAT3-V144M characterized by perturbed nucleocytoplasmic 114 distribution and increased formation of cytoplasmic foci that can be suppressed by co-expression with 115 ADAT2. The formation of aberrant cytoplasmic aggregates exhibited by ADAT3-V144M in the absence 116 of ADAT2 co-expression suggests that the V144M mutation causes increased propensity for protein 117 misfolding and aggregation which can be ameliorated by interaction with the ADAT2 subunit and import 118 into the nucleus. 119 120 ADAT3-V144M maintains interactions with ADAT2 but exhibits increased propensity to homo-121 oligomerize 122
The perturbed subcellular localization of ADAT3-V144M along with its accumulation in 123 cytoplasmic foci suggests that the V144M mutation could be altering the structure of ADAT3 leading to 124 misfolding and aggregation. Furthermore, the reduction in ADAT3-V144M cytoplasmic aggregates by 125 ADAT2 co-expression suggests that assembly of ADAT3 with ADAT2 is critical for preventing ADAT3 126 self-association, especially in the context of the ADAT3-V144M variant. To analyze the interaction 127 between ADAT3-V144M and ADAT2, we co-expressed GFP-tagged ADAT3-WT or V144M with ADAT2 128 tagged with the twin Strep-tag (32) in 293T human embryonic kidney cells. The Strep-tag allows for one-129 step affinity purification of Strep-tagged proteins on streptactin resin under native conditions followed by 130 gentle elution with biotin to preserve any protein-protein interactions. After purification of Strep-ADAT2 131 on streptactin resin, we found that comparable levels of GFP-ADAT3-WT and GFP-ADAT3-V144M were 132 interacting with ADAT2 ( Figure 2A ). These results indicate that ADAT3-V144M interacts with similar 133 efficiency as ADAT3-WT with ADAT2, consistent with the ability of ADAT2 to induce the translocation 134 of either ADAT3-WT or V144M into the nucleus ( Figure 1A) . 135
To further analyze the interaction between ADAT2 and ADAT3-V144M, we used a reciprocal 136 approach in which we purified ADAT3 and examined the amount of co-purifying ADAT2. For these assays, 137
we transiently expressed either ADAT3-WT or V144M fused to a carboxy-terminal Strep-tag for 138 purification and elution of ADAT2/3. Since ADAT2 levels have been shown to be limiting for the formation 139 of ADAT2/3 complexes in human cells (15), we co-expressed His-tagged ADAT2 with either ADAT3-140 167
ADAT3-V144M is targeted by the cytoplasmic HSP60 and TRiC chaperonin complexes 168
The perturbed subcellular localization of ADAT3-V144M combined with its increased propensity 169 to aggregate prompted us to investigate whether ADAT3-V144M also displayed interactions with other 170 cellular proteins. For proteomic analyses, we expressed either the WT or V144M versions of ADAT3 as 171 fusion proteins with the FLAG epitope tag in 293T human embryonic kidney cells in order to facilitate the 172 expression and purification of ADAT3 complexes. Following immunoprecipitation (IP), the purified 173 samples were analyzed by SDS-PAGE and silver stain to identify ADAT3-interacting proteins. While no 174 observable bands were found in a control purification from cells transfected with vector alone, we could 175 detect the purification of FLAG-ADAT3-WT or V144M ( Figure 3A , arrowhead) along with an additional 176 band at ~60 kDa specifically enriched with the ADAT3-V144M purification ( Figure 3A , arrow). Proteomic 177 analysis of the entire eluted samples from control and ADAT3 purifications by liquid chromatography-178 mass spectrometry (LC-MS) validated the successful recovery of ADAT3-WT or ADAT3-V144M from 179 cellular extracts ( Figure 3B , Supplemental Table 1 ). Notably, LC-MS analysis also revealed the 180 copurification of heat shock protein 60 (HSP60) and all eight subunits of the TCP-1 Ring Complex (TRiC, 181 also known CCT) with ADAT3-V144M but not ADAT3-WT ( Figure 3B , Supplemental Table 1 ). HSP60 182 and TRiC subunits were identified among the top 20 scoring matches in the ADAT3-V144M purification. 183
The HSP60 protein forms a homo-oligomeric chaperonin complex consisting of a double-heptameric ring 184 that associates with misfolded proteins in the cytoplasm and mitochondria to provide an environment for 185 protein refolding (33-36). Similar to HSP60, TRiC is a major eukaryotic cytoplasmic chaperonin that is 186 responsible for the correct folding of endogenous client proteins that are prone to misfolding (34,37). The 187 interaction of chaperonin complexes with ADAT3-V144M is consistent with a misfolding and aggregation 188 defect caused by the V144M mutation as suggested above by microscopy and co-IP. We also note that 189 peptides matching ADAT2 were not identified in the purifications of either ADAT3-WT or V144M when 190 purified without co-expression of ADAT2. The lack of copurification of ADAT2 with over-expressed 191 ADAT3 agrees with previous findings that the levels of endogenous ADAT2 are limiting for formation of 192 an ADAT2/3 complex (15). 193 To verify and characterize the interaction between HSP60 and ADAT3-V144M, we performed co-194 IP experiments followed by immunoblotting. For a subset of these assays, we co-expressed His-tagged 195 ADAT2 with either WT or V144M versions of FLAG-ADAT3 to investigate whether ADAT2 influences 196 HSP60 interactions as seen above. While a low level of HSP60 copurified with ADAT3-WT, we detected 197 a significantly increased amount of HSP60 associated with the ADAT3-V144M variant ( Figure 3C , HSP60, 198 lanes 7 and 8). Similar to the oligomerization results described above, the interaction between HSP60 and 199 ADAT3-V144M could be greatly suppressed by co-expression with ADAT2 ( Figure 3C Using an analogous co-IP approach, we also found that the TRiC complex subunits TCP1 and 206 CCT7 exhibited significantly increased association with ADAT3-V144M compared to wildtype ADAT3 207 ( Figure 3D and E, lanes 7 and 8). Similar to ADAT3 interaction with HSP60, we also found that co-208 expression of ADAT2 could suppress the association between the TRiC complex with ADAT3-WT while 209 significantly reducing the amount of TRiC associated with ADAT3-V144M ( Figure 3D and E, compare 210 lanes 7 and 8 to 9 and 10). The targeting of either ADAT3-WT or V144M by cellular chaperonin complexes 211 provide evidence that ADAT3-WT is prone to misfolding with the V144M mutation further exacerbating 212 the misfolding and/or aggregation phenotype. Furthermore, these studies reveal a critical role for ADAT2 213 in facilitating the proper folding of ADAT3 in addition to its role in the nuclear import of assembled 214 ADAT2/3 complexes. 215
Purified ADAT2/3 complexes assembled with ADAT3-V144M exhibit defects in adenosine deaminase 217 activity 218
The aggregation phenotype exhibited by ADAT3-V144M indicates that the V144M mutation is 219 likely to be altering the folding and structure of ADAT3 that could compromise the activity of the ADAT2/3 220 complex. To probe if the V144M mutation affects ADAT3 activity in wobble inosine formation, we 221 investigated the biochemical properties of the purified ADAT2/3 complexes assembled with either Strep-222 ADAT3-WT or ADAT3-V144M that were described above ( Figure 2B ). We analyzed the purified 223 ADAT2/3 complexes for enzymatic activity using an adenosine deaminase assay based upon the separation 224 of digested RNA nucleoside products by thin layer chromatography (TLC) ( Figure 4A ). For this assay, in 225 vitro transcribed tRNA substrates were internally radiolabeled at adenosine residues using [a- Using this assay, we found that purified ADAT2/3 complexes assembled with ADAT3-WT 231 exhibited adenosine deaminase activity on both pre-or mature tRNA-Val-AAC as evidenced by the 232 formation of inosine ( Figure 4B and C, IMP, lanes 2-4). In contrast to ADAT2/3-WT complexes, purified 233 ADAT2/3-V144M complexes were significantly diminished in adenosine deaminase activity on either pre-234 or mature tRNA-Val-AAC ( Figure 4B and C, compare lanes 2-4 to lanes 5-7). Based upon the 5-fold 235 dilutions of enzyme, we found that ADAT2/3 complexes assembled with ADAT3-V144M displayed at 236 least a 25-fold decrease in adenosine deaminase activity compared to complexes assembled with ADAT3-237 WT on either pre-or mature-tRNA-Val-AAC ( Figure 4B and C). These findings reveal that while ADAT3-238 V144M can still associate with ADAT2 in human cells, the variant ADAT2/3-V144M complexes exhibit 239 major defects in adenosine deaminase activity. 240
241

Human patients with homozygous ADAT3-V144M mutations exhibit perturbations in cellular tRNA 242 adenosine deaminase activity 243
The results thus far provide evidence that ADAT3-V144M exhibits aberrant subcellular 244 localization, increased propensity to aggregate, and defects in adenosine deaminase activity. To examine 245 the molecular effects of the V144M mutation in the human population, we generated lymphoblastoid cell 246 lines (LCLs) from two unrelated human patients harboring homozygous V144M missense mutations in the 247 ADAT3 gene (referred to as V144M-LCLs generated from patients 1 and 2; P1 and P2; Figure 5A -B). P1 248 (09DG0640) has been described in detail previously by our group (16, 18) . Briefly, this is a 6-year old 249 female with severe ID, short stature, microcephaly, strabismus, deafness and history of global 250 developmental delay. She is part of a consanguineous family with three similarly affected siblings, one of 251 whom (09DG00479) is shown in Figure 5C . P2 (11DG1699) is a 24-year old male with severe ID, short 252 stature, microcephaly, strabismus and history of global developmental delay as a child. P2 is part of a 253 consanguineous family with a similarly affected brother (17). LCLs generated from both ID-affected 254 individuals with homozygous V144M mutations were compared to control lymphoblasts from an ethnically 255 matched, healthy, unrelated individual. 256
We first examined the levels of ADAT3 protein in the LCLs to determine if the expression or 257 stability of ADAT3 was affected by the V144M mutation. Based upon immunoblotting of whole cell 258 lysates, no major change in the endogenous levels of ADAT3 was detected between WT and V144M-LCLs 259 ( Figure 5D , ADAT3). Moreover, we detected no significant change in the levels of the ADAT3 260 heterodimeric binding subunit, ADAT2, between any of the LCLs ( Figure 5D , ADAT2). The comparable 261 steady-state levels of wildtype ADAT3 and the V144M variant suggest the V144M mutation could be 262 affecting ADAT3 function without affecting the levels of protein. 263 We next employed the TLC-based IMP detection assay described above to investigate whether the 264 V144M mutation affects adenosine deaminase activity in the cells of ID-affected individuals expressing 265 only the ADAT3-V144M variant. Due to the limited amounts of ADAT2/3 found in LCLs combined with 266 the lack of an effective antibody for immunoprecipitation (data not shown), we optimized an in vitro 267 adenosine deaminase activity assay using whole cell extracts prepared from the human LCLs described 268 above. This was made possible since previous studies have shown that the ADAT2/3 enzyme complex is 269 the only known cellular activity that catalyzes wobble inosine formation in tRNA (9). Since we found that 270 purified ADAT2/3 complexes exhibit defects in adenosine deaminase activity on pre-and mature tRNA-271
Val-AAC (Figure 4 ), we tested whether the LCL extracts also displayed differences in activity on these 272 same substrates. 273
While no detectable IMP was detected in tRNA substrates pre-incubated with buffer alone, we 274 could readily detect the formation of IMP in both pre-and mature-tRNA-Val-AAC after pre-incubation 275 with whole cell extracts prepared from WT-LCLs ( Figure 5E and F, lanes 2-4). In addition to IMP, we also 276 detected a faster-migrating adenosine modification that is consistent with the formation of 1-277 methyladenosine ( Figure 5E , m1A) (38). Since tRNA-Val-AAC has been shown to contain m1A at position 278 58 in human cells (40), the formation of m1A on the tRNA substrates is likely due to endogenous 279 TRMT6/TRMT61 complexes present in cellular extracts (41). The formation of m1A provides an additional 280 control for normalizing cellular activity since they are catalyzed by two different enzyme complexes. 281
Agreeing with the activity defect discovered above with purified ADAT3-V144M, we found that 282 V144M-LCL extracts exhibited at least a 25-fold decrease in the generation of inosine in pre-tRNA-Val-283 AAC ( Figure 5E , lanes 5-10). The defect in adenosine deaminase activity for pre-tRNA-Val-AAC was not 284 due to general loss of activity of the V144M-LCL extracts or underloading since the formation of m1A was 285 similar between all three extracts ( Figure 5E, m1A) . Interestingly, we found that WT-and V144M-LCL 286 extracts displayed a similar level of adenosine deaminase activity on mature tRNA-Val-AAC ( Figure 5F ). 287
Thus, the V144M mutation appears to affect adenosine deaminase activity on the pre-tRNA-Val-AAC 288 substrate but not processed, mature tRNA-Val-AAC. As an additional control, we compared the level of 289 adenosine deaminase activity in the V144M-LCLs to a completely different LCL line procured from a 290 healthy, wildtype individual of similar age and also detected a similar decrease in tRNA modification 291 activity on pre-tRNA-Val-AAC associated with the V144M-LCL extracts (Supplemental Figure 2) . These 292 findings uncover a severe modification defect associated with the ADAT3-V144M variant in human 293 individuals on tRNA-Val-AAC that affects adenosine deaminase activity on the unprocessed form of tRNA 294 greater than the mature form. Importantly, these findings suggest that individuals expressing only the 295 ADAT3-V144M variant are likely to be compromised but not completely abolished in adenosine deaminase 296 activity on wobble inosine-containing tRNA substrates in vivo. 297 298 Individuals homozygous for the ADAT3-V144M mutation exhibit decreased wobble inosine 299 modification in some but not all tRNAs 300
Based upon the adenosine deaminase activity defects exhibited by ADAT2/3-V144M complexes, 301
we next investigated the wobble inosine status of tRNA-Val-AAC isolated from the V144M-LCLs of ID-302 affected individuals. Since inosine is read as G by reverse transcriptases (42-44), the formation of inosine 303 at the wobble position of tRNA-Val-AAC can be directly detected by sequencing of amplified cDNA 304 obtained by reverse transcription of cellular tRNA. In WT-LCLs, the majority of wobble adenosines in 305 tRNA-Val-AAC were converted to inosine as evidenced by the presence of a predominant "G" peak at 306 position 34 ( Figure 6A , Control-WT1). We also compared the level of wobble inosine modification in the 307
WT-LCLs to a completely different LCL line procured from a healthy individual of a similar age and found 308 a similar extent of wobble inosine modification ( Figure 6A , Control-WT2). Notably, the level of wobble 309 inosine modification in tRNA-Val-AAC was greatly reduced in both V144M-LCLs with the majority of 310 peak signal at the wobble position being the unmodified "A" ( Figure 6A , V144M-P1 and P2). These results 311 provide the first evidence that the ADAT3-V144M mutation and its associated molecular defects have an 312 impact on the levels of tRNA wobble inosine modification in vivo. 313
Based upon the inosine modification defect in tRNA-Val-AAC, we also investigated whether 314 additional tRNAs containing inosine at the wobble position were affected by the ADAT3-V144M mutation. 315
Due to technical challenges in RT-PCR sequencing analysis caused by the diverse number of tRNA 316 isodecoder variants encoded by mammalian genomes, we investigated the modification status of human 317 tRNAs using poisoned primer extension assays with a ddCTP terminator, to distinguish I34 (terminated with 318 ddCTP) from A34, terminated at the next guanosine (Fig. 6B-D) . Using this assay, we observed substantially 319 reduced frequency of I34 modification for tRNA-Val-AAC and tRNA-Ile-AAU ( Fig. 6B and C ), but only a 320 slight defect in modification of tRNA-Leu-AAG ( Figure 6D ). These results suggest that not all tRNAs are 321 affected to the same extent by the ADAT3-V144M mutation, consistent with the reduced but not abolished 322 adenosine deaminase activity detected in V144M-LCL extracts. Taken altogether, these studies uncover a 323 wobble inosine hypomodification defect for particular tRNAs in the cells of individuals that are 324 homozygous for the ADAT3 V144M mutation, consistent with the multiple perturbations in ADAT3 325 localization and activity associated with the V144M mutation. 326 327 Discussion 328
The molecular consequences of the ID-causing ADAT3-V144M mutation have previously been 329 unknown. Surprisingly, the V144M mutation has little to no effect on the steady-state levels of ADAT3 nor 330 on binding to the ADAT2 subunit. However, the ADAT3-V144M mutation significantly alters the 331 subcellular localization properties of ADAT3 and greatly compromises the adenosine deaminase activity 332 of ADAT2/3 complexes assembled with ADAT3-V144M. While the V144M mutation is predicted to be a 333 relatively minor change since valine and methionine represent amino acid residues with hydrophobic side 334 chains of similar molecular size, modeling with the TadA homodimeric complex suggests that the mutation 335 could alter a loop located on the surface of the ADAT3 protein (16). The alteration in ADAT3 structure 336 could then affect the biochemical properties of the assembled ADAT2/3 complex such as substrate binding 337 or adenosine deaminase activity on certain tRNA substrates. Intriguingly, studies with Trypanosoma brucei 338 homologs of Tad2p/Tad3p have revealed a role for ADAT3 in substrate tRNA binding and coordination of 339 a single zinc ion (39, 45) . This would suggest that the ADAT3-V144M mutation may alter the substrate 340 recognition site of the ADAT2/3 complex thereby affecting the binding of or catalysis step on certain tRNA 341 substrates. Indeed, we find that the ADAT3-V144M mutation has differential effects on wobble inosine 342 levels with certain tRNAs exhibiting a substantial decrease in tRNA modification while others display little 343 to no major change. This differential effect could be due to the recognition mechanism of human ADAT2/3, 344 which targets tRNA anticodon loops for inosine modification based upon their structural context rather than 345 simply their sequence alone (46). Further refinement using RNA binding assays and kinetics will provide 346 insight into the specific effect of the V144M mutation on ADAT2/3 enzymatic activity that influence 347 inosine modification levels in vivo. Due to the intricate dynamics of tRNA processing (56-58), the disruption of nucleocytoplasmic 367 localization by the V144M mutations provides yet another possible contributor to the decreased levels of 368 wobble inosine tRNA modification in ID-affected individuals. The increased propensity of ADAT3-369 V144M to localize to the nucleus indicates that there could be a relative decrease in the amount of 370 cytoplasmic ADAT3 in ID-affected individuals with homozygous ADAT3-V144M mutations. The 371 cytoplasmic population of ADAT3 assembled with ADAT2 could play a role in modifying tRNAs that have 372 been exported without prior wobble inosine modification by nuclear ADAT2/3. Thus, the disruption of the 373 nucleocytoplasmic ratio by the V144M mutation combined with the activity defect of ADAT2/3-V144M 374 complexes could lead to the reduction in wobble inosine modification levels observed in the tRNAs of 375 individuals homozygous for the ADAT3-V144M mutation. In addition, newly-exported tRNAs lacking 376 inosine could undergo retrograde transport back into the nucleus to be modified by nuclear ADAT2/3 377 (59,60). Since ADAT2/3-V144M complexes in extract appear to be defective in modifying pre-but not 378 mature tRNA, retrograde transport could play a critical role in providing at least enough tRNA wobble 379 inosine modification for sufficient translation to sustain cell viability. 380
It is unknown why the ADAT3-V144M mutation causes increased localization to the nucleus. 381
Possible reasons include fortuitous interaction with nuclear import factors, increased interaction with 382 ADAT2 which is responsible for ADAT3 import or loss of interaction with a cytoplasmic retention factor. 383
Investigation of the ADAT3-interactome revealed no obvious candidates that suited any of these scenarios, 384 which is not surprising considering that these factors are likely to be transiently associated. Another 385 possibility is that the increased level of ADAT3 in the nucleus is due to the import of ADAT3 oligomers 386 into the nucleus by ADAT2. Thus, for every ADAT2 imported into the nucleus, there could be more than 387 one ADAT3-V144M subunit translocated alongside. 388
Based upon the findings, we hypothesize that a certain level of wobble inosine modification in 389 particular tRNAs is necessary for the expression of cellular mRNAs that are critical for proper cellular 390 physiology and human development. Consistent with this prediction, studies in yeast Schizosaccharomyces 391 pombe and the plant Arabodopsis thaliana have shown that a decrease in tRNA wobble inosine 392 modifications leads to temperature sensitivity, cell cycle arrest and growth retardation (12, 14) . Moreover, 393 genome wide studies predict numerous highly-expressed genes that are dependent upon ADAT2/3-394 catalyzed wobble inosine modification for translation (61). Thus, the V144M mutation could alter the 395 cellular proteome in multiple tissues with particularly acute effects in the brain on neural growth and 396
differentiation. 397 398
Materials and Methods 399
Human subjects 400 
Protein purification and analysis 434
Transient transfection and cellular extract production were performed as previously described (63). 435
In brief, 2.5x10 6 293T HEK cells were transiently transfected by calcium phosphate DNA precipitation 436 with 10-20 µg of plasmid DNA followed by preparation of lysate by hypotonic freeze-thaw lysis 48 hours 437 post-transfection. For anti-FLAG purification, whole cell extract from transiently transfected cells cell lines 438
(1 mg of total protein) was rotated with 20 µL of Anti-DYKDDDDK Magnetic Beads (Takara BioUSA, 439
Clontech or Syd labs) for 2 h at 4° C in lysis buffer (20 mM HEPES at pH 7.9, 2 mM MgCl2, 0.2 mM 440 EGTA, 10% glycerol, 1 mM DTT, 0.1 mM PMSF, 0.1% NP-40) with 200 mM NaCl. Resin was washed 441 three times using the same buffer followed by RNA extraction or protein analysis. Strep-tagged proteins 442 were purified using MagSTREP "type3" XT beads, 5% suspension (IBA Lifesciences) under similar 443 conditions as with anti-FLAG purifications and eluted with desthiobiotin. 444
Protein identification was performed by the URMC Mass Spectrometry Resource Laboratory. 445
Briefly, protein samples were reduced, alkylated and digested in solution with trypsin followed by 446 purification and desalting on an analytical C18 column tip. Peptide samples were analyzed by HPLC 447 chromatography coupled with electrospray ionization on a Q Exactive Plus Hybrid Quadrupole-Orbitrap 448 mass spectrometer (Thermo Fisher). Protein identification through tandem mass spectra correlation was 449 performed using SEQUEST and Mascot. 450 Cellular extracts and purified protein samples were fractionated on NuPAGE Bis-Tris 451 polyacrylamide gels (Thermo Scientific) followed by transfer to Immobilon FL PVDF membrane 452 (Millipore) for immunoblotting. For analysis of LCL extracts, 5x10 6 lympoblast cells were harvested and 453 proteins were extracted using radioisotope immunoprecipitation assay (RIPA) buffer (50 mM TrisHCl, pH 454 7.5, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 2mM EDTA). Antibodies were 455 against the following proteins : FLAG epitope tag (L00018, Sigma), 6xHis tag (MA1-21315, Thermo 456 
Adenosine deaminase assays 464
Internally-radiolabeled tRNA substrates were prepared by T7 in vitro transcription of DNA 465 templates generated by PCR amplification. Oligonucleotides containing the T7 promoter upstream of tRNA 466 sequences were PCR amplified using Herculase II DNA polymerase or Taq DNA Polymerase (New 467 England Biolabs) followed by agarose gel purification of PCR amplification products. In vitro transcription 468 was performed using Optizyme T7 RNA polymerase (Fisher Scientific) with 10 mM each of UTP, CTP 469 and GTP, 1mM of ATP and 250 µCi of [α-32 P]-ATP (800Ci/mmol, 10mCi/ml). In vitro transcription 470 reactions were incubated at 37° C for 2 hours followed by DNase treatment and purification using RNA 471
Clean and Concentrator columns (Zymo Research). Full-length tRNA transcripts were verified on a 15% 472
Polyacrylmide-urea gel stained with SYBR Gold nucleic acid stain (Thermo Fisher). Before conducting 473 enzymatic assays, all tRNA substrates were refolded by thermal denaturation at 95°C for 2 minutes in buffer 474 containing a final concentration 5 mM TRIS ph7.5 and 0.16 mM EDTA, quick chilling on ice for 2 min 475 and refolding at 37°C in the presence of Hepes pH 7.5, MgCl2, and NaCl. 476
For adenosine deaminase assays, ~30 ng of refolded tRNA substrate was incubated with titrations 477 of enzyme starting at the highest concentration of ~15 nM of Strep-purified ADAT3. Serial dilutions 478 occurring in 1/5 increments then were carried out in the presence of 12.5 µg/mL BSA. For enzymatic 479 reactions from extracts, the highest concentration of protein started at ~20 ug of total protein in the reaction. 480
Dilutions occurring in 1/5 increments were then carried out. Reactions were incubated at 37°C for 60 481 minutes and RNA was purified using RNA Clean and Concentrator columns. The tRNA was eluted in 20 482 µL of water and 10 µL was subjected to nuclease P1 digestion overnight in total volume of 13 µL and 0. 
RNA analysis 488
RNA extraction was performed on 10 x 10 6 human lyphoblastoid cell lines using Trizol LS reagent 489 (Thermo Fisher). For RT-PCR, total RNA (~1.25 µg) was reverse transcribed for tRNA-Val-AAC using 490 Superscript IV enzyme followed by the QIAquick PCR purification kit. cDNA was then PCR amplified 491 using Herculase II DNA polymerase (Agilent Genomics). The PCR product was gel extracted and analyzed For primer extension assays to monitor inosine modification status, oligonucleotides were 5' end 499 labeled and purified as previously described (64). In a 5 µL annealing reaction, 0.25 -1 pmol of labeled 500 primers were annealed to 0.6 µg of bulk RNA by incubation for 3 min at 95°C followed by slow cooling 501 and incubation for 30 min at 50-55°C. The annealing product was then extended using 64 U Superscript III 502 (Invitrogen) in a 10 µL reaction containing 1X First Strand buffer, 2 mM ddCTP, 0.5 mM of each of the 503 other dNTPs and 10 mM MgCl2 at 50 -55°C for 1 h. Reactions were stopped by addition of 2 X RNA 504 loading dye containing 98% formamide, 10 mM EDTA, 1 mg/mL bromophenol blue, and 1 mg/mL xylene 505 cyanol, resolved on a 7M urea -15% polyacrylamide gel, and the dried gel was imaged on a Typhoon 506 phosphorimager and quantified as described (65) Lab for microscopy resources and discussion. We also thank the participating human subjects for donating 526 their blood samples for research. 527 Representative TLC plates from adenosine deaminase activity assays using the indicated tRNA substrates with LCL extracts isolated from the wildtype control individual and persons harboring homozygous V144M mutations. Adenosine deaminase assays were repeated at least 2x with extracts generated from LCLs grown at different times with similar results. Supplemental Figure 2 . Individuals homozygous for the ADAT3-V144M mutation exhibit defects in adenosine deaminase activity relative to wildtype (WT) control LCLs. TLC plates from adenosine deaminase activity assays using the indicated tRNA substrates with LCL extracts isolated from an additional, unrelated wildtype control (WT-2) individual, the previously-described wildtype control individual (WT-1) and patients harboring homozygous V144M mutations (P1 and P2).
Figure Legends
